Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday’s Mid-Day Session
Gainers
MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Important Biotech Catalysts For September 12, 2022 – End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Mersana Therapeutics’ (NASDAQ:MRSN) lead candidate…
Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary
Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F…
Dynavax’s Adjuvant Based COVID-19 Shot Shows Robust Immune Response, Safety In Younger Populations
Hong Kong-listed Clover Biopharmaceuticals Ltd announced data from a global Phase 2/3 trial evaluating its COVID-19 vaccine candidate, SCB-2019, in adolescents (aged 12 to 17 years).
Dynavax Technologies: Q2 Earnings Insights
Dynavax Technologies (NASDAQ:DVAX) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell
• Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
110 Biggest Movers From Friday
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
56 Stocks Moving In Friday’s Mid-Day Session
Gainers
Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.
Dynavax Technologies Q1 EPS $0.26 Beats $0.24 Estimate, Sales $114.00M Miss $154.30M Estimate
Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.24 by 8.33 percent. This is a 2500 percent increase over earnings of $0.01 per share from